Phase
Condition
Infertility
Female Hormonal Deficiencies/abnormalities
Polycystic Ovarian Syndrome
Treatment
Vitamin D
Placebo
Clinical Study ID
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Premenopausal
Aged 18-40 years
Irregular long menstrual cycles (>35 days)
PCOS according to the Rotterdam criteria
Agree for transvaginal ultrasound
Exclusion
Exclusion Criteria:
Use of hormonal medication (including contraception) within 3 months prior to studyinclusion, except the use of a progestogen to induce withdrawal bleeding every 3months
History of any medical condition or medications that may predispose to vitamin Dsensitivity, altered vitamin D metabolism and/ or hypercalcemia, including activetuberculosis or current therapy for tuberculosis, sarcoidosis, history of renal/ureteral stones, parathyroid disease, renal or liver failure or current use ofanti-convulsants
Use of insulin-sensitizing drugs, lipid lowering drugs or anti-hypertensive
Anticipated to use the above medications in the coming one year
Known type 2 diabetes mellitus
Refusal to join the study
Abnormal blood calcium level
For those on supplements, we asked them to stop their own supplements.
Study Design
Study Description
Connect with a study center
Kwong Wah Hospital
Hong Kong,
Hong KongActive - Recruiting
Princess Margaret Hospital
Hong Kong,
Hong KongSite Not Available
Queen Mary Hospital, University of Hong Kong
Hong Kong,
Hong KongActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.